ISBN:
9780443122002
Copyright:
2025
Publication Date:
07-15-2024
Page Count:
1536
Imprint:
Mosby
List Price:
$48.99
Mosby's 2025 Nursing Drug Reference, 38th Edition
by Linda Skidmore-Roth, RN, MSN, NP
Paperback
ISBN:
9780443122002
Copyright:
2025
Publication Date:
07-15-2024
Page Count:
1536
Imprint:
Mosby
List Price:
$48.99
In Stock
Most review copies are eBooks – how fast!
A review copy request is most likely to be fulfilled as an eBook on VitalSource rather than a print product, unless no eBook is available. eBooks become available in as little as a few hours. Print products will take between 7 and 10 days to arrive. To request a print copy, please contact us through the Evolve Support Center for further assistance or contact your Education Solutions Consultant.
Any student who attempts to request a review copy will be reported to the school's faculty and administration.
Choose the drug handbook trusted by nurses for more than 35 years! Mosby's 2025 Nursing Drug Reference makes it easy to find the most vital information on the drugs that nurses administer most frequently. More than 5,000 drugs are profiled — including more than 25 new entries for drugs recently approved by the FDA. And no other drug guide places a higher emphasis on patient safety, with Black Box Warnings for dangerous adverse reactions, Safety Alerts for situations requiring special attention, and a focus on both common and life-threatening side effects. Adding more drug monographs and resources on Evolve, Mosby’s NDR proves there is a difference in drug guides. It’s Mosby’s bestselling drug reference for nurses!
-
- NEW! Drug monographs for more than 25 newly released, FDA-approved medications equip users with the latest drug information including generic names, trade names, pronunciations, do-not-confuse drugs, action, uses, contraindications, precautions, dosages and routes, side effects, pharmacokinetics, interactions (including drug/herb, drug/food and drug/lab test), nursing considerations, treatment of overdose, patient/family teaching, and more.
- NEW! Several online-only drug monographs are added to the companion Evolve website, creating an overall total of more than 100 Evolve-only drug monographs for lesser-used medications.
- NEW! Combinations heading for selected monographs highlight common combinations.
- More than 5,000 generic and trade-name drugs are profiled, covering almost every drug that users will administer in practice or in clinicals.
- Alphabetical organization by generic name provides quick and easy access to specific drugs, with both trade and generic names listed in the index.
- Bolded coverage of IV drug administration highlights dosage and IV administration instructions, including safety considerations and Y-site, syringe, and additive compatibilities.
- Nursing Process steps are used as the framework for organizing all nursing care information.
- Complete pharmacokinetic information is summarized in a table and includes the mechanism and absorption of the drug as well as its action, duration, and excretion.
- Side effects information is organized by body system and identified as common or life threatening, showing signs to watch for during assessments.
- High Alert headers highlight drugs that pose the greatest risk if administered improperly.
- Black Box Warnings provide alerts to FDA warnings of dangerous or life-threatening drug reactions.
- Overview of drug categories explains the safe administration of common classes of drugs, as well as their common side effects and interactions.
- Flexible, water-resistant cover provides durability in the clinical setting.
-
INDIVIDUAL DRUG MONOGRAPHS
APPENDICES
A. Selected New Drugs
avacincaptad pegol
bexagliflozin
bimekizumab
capivasertib
daprodustat
efbemalenograstim
eflornithine
elacestrant
elranatamab
epcoritamab
etrasimod
exagamglogene
fezolinetant
fruquintinib
ganaxolone
gepirone
glofitamab
iptacopan
lecanemab
toripalimab
lotilaner
lovotibeglogene autotemcel
maralixibat
maribavir
mavacamten
mirikizumab
mitapivat
momelotinib
motixafortide
nedosiran
nirmatrelvir/ritonavir
nirogacestat
nirsevimab-alip
perfluorohexyloctane
pirtobrutinib
quizartinib
repotrectinib
retifanlimab
rezafungin
rozanolixizumab-noli
somatrogon-ghla
sulbactam/durlobactam
talquetamab
tapinarof
tofersen
toripalimab
vamorolone
velmanase
zavegepant
zilucoplan
zuranolone
B. Ophthalmic, Nasal, Topical, and Otic Products
C. Vaccines and Toxoids
D. Recent FDA Drug Approvals
INDEX
EVOLVE WEBSITE
In Stock
Most review copies are eBooks – how fast!
A review copy request is most likely to be fulfilled as an eBook on VitalSource rather than a print product, unless no eBook is available. eBooks become available in as little as a few hours. Print products will take between 7 and 10 days to arrive. To request a print copy, please contact us through the Evolve Support Center for further assistance or contact your Education Solutions Consultant.
Any student who attempts to request a review copy will be reported to the school's faculty and administration.